We are live on ! Find out more
FIS

FCPM III Services Portfolio holdings

AUM $722M
1-Year Est. Return 73.61%
This Fund
S&P 500
This Quarter Est. Return
-2.74%
1 Year Est. Return
+73.61%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$678M
AUM Growth
-$29.2M
Cap. Flow
+$48M
Cap. Flow %
7.07%
Top 10 Hldgs %
100%
Holding
7
New
1
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
BCYC
Bicycle Therapeutics
BCYC
+$48M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 99.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DYN icon
1
Dyne Therapeutics
DYN
$3.88B
$277M 40.83%
7,845,364
NAMS icon
2
NewAmsterdam Pharma
NAMS
$3.47B
$227M 33.52%
11,831,461
ENGN icon
3
enGene Therapeutics
ENGN
$125M
$81.8M 12.07%
8,677,951
REPL icon
4
Replimune Group
REPL
$882M
$43.8M 6.46%
4,866,449
BCYC
5
Bicycle Therapeutics
BCYC
$290M
$43M 6.34%
+2,122,892
New +$48M
ENGNW icon
6
enGene Therapeutics Warrants
ENGNW
$3.53M
$3.42M 0.51%
2,878,148
ACHL
7
DELISTED
Achilles Therapeutics
ACHL
$1.95M 0.29%
2,390,050

Similar funds

FCPM III Services's Q2 2024 Portfolio in Review

As of Q2 2024, FCPM III Services held 7 positions worth $678M, down 4.1% from $707M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

FCPM III Services deployed $48M of net new capital in Q2 2024, opening 1 new position. Its largest new stake was Bicycle Therapeutics: 2,122,892 shares worth $43M.

By sector, the portfolio is most concentrated in Healthcare at 99% of assets, up from 98% a quarter earlier.

  • FCPM III Services's largest Q2 2024 buy was Bicycle Therapeutics: 2,122,892 shares worth $43M.
  • FCPM III Services's ten largest holdings make up 100% of its $678M portfolio in Q2 2024.
  • FCPM III Services opened 1 new position and closed 0 in Q2 2024.
  • FCPM III Services's portfolio value fell 4.1% quarter-over-quarter to $678M.

Based on FCPM III Services's 13F filing for Q2 2024, filed 8 Aug 2024.